[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"glasgow-blatchford-score\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:glasgow-blatchford-score":36},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":12,"acronym":4,"eligibilityCriteria":13,"healthyVolunteers":10,"sex":14,"minAge":15,"maxAge":4,"enrollmentInfo":16,"targetDuration":4,"studyType":19,"phases":4,"briefSummary":20,"conditions":21,"keywords":4,"overallStatus":24,"whyStopped":4,"lastUpdateSubmitDate":25,"lastUpdatePostDateStruct":26,"startDateStruct":29,"completionDateStruct":31,"leadSponsor":33,"locationsCount":5},"100599806",false,"NCT07089277","External Validation of the Glasgow-Blatchford Bleeding Score in a Tunisian Population","Inclusion Criteria:\n\n* Adult patients (≥18 years) presenting with non-traumatic upper gastrointestinal bleeding\n\nExclusion Criteria:\n\n* patients under 18 years of age.\n\nDiagnosis of external hemorrhoids with mucosal lesions.\n\nPatients who do not consent, are lost to follow-up, or have incomplete data.","ALL","18 Years",{"count":17,"type":18},250,"ESTIMATED","OBSERVATIONAL","This study aims to externally validate the Glasgow-Blatchford Score (GBS) in a Tunisian population presenting with non-traumatic upper gastrointestinal bleeding. Despite advances in endoscopic management, early risk stratification remains essential to guide clinical decision-making. In Tunisia, the routine hospitalization of all patients for observation presents a challenge, highlighting the need for reliable prognostic tools.\n\nThe study is designed as a multicenter, descriptive, and analytical investigation across several emergency departments. Adult patients (≥16 years) will be included, with follow-up conducted at 30 days to assess for adverse outcomes including rebleeding, the need for hemostasis, complications, and mortality.\n\nClinical and epidemiological data will be collected using a standardized form. Statistical analysis will evaluate the predictive performance of the GBS, focusing on sensitivity, specificity, and predictive values for 30-day outcomes.\n\nThe results are expected to determine whether GBS is a valid and useful tool for risk assessment in the Tunisian context, potentially aiding in more efficient and targeted patient management.",[22,23],"Upper Gastrointestinal Bleeding (UGIB)","Glasgow-Blatchford Score","RECRUITING","2025-07-21",{"date":27,"type":28},"2025-07-28","ACTUAL",{"date":30,"type":28},"2024-01-01",{"date":32,"type":18},"2025-12-30",{"name":34,"class":35},"Hôpital Universitaire Sahloul","OTHER",""]